Onconetix, Inc. (ONCO): auditor change — Blue Water Biotech auditor resigns; EisnerAmper appointed as new independent auditor

Onconetix, Inc.

Mayer Hoffman McCann (MHM) resigned as independent auditor effective June 29, 2023.
No disagreements with MHM on accounting principles or audit scope during fiscal years 2021-2022 or interim period.
Previously disclosed material weakness in internal controls (lack of staff for segregation of duties) noted.
Audit committee appointed EisnerAmper LLP as new independent auditor for FY 2023 on July 6, 2023.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Onconetix, Inc. engaged EisnerAmper LLP as its auditor.

Action: engagement
Auditor: EisnerAmper LLP

Exact text from the filing

On July 6, 2023, the Audit Committee appointed EisnerAmper LLP (“EA”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 and related interim periods.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Mayer Hoffman McCann P.C. resigned as auditor of Onconetix, Inc..

Action: resignation
Auditor: Mayer Hoffman McCann P.C.

Exact text from the filing

On June 29, 2023, Mayer Hoffman McCann P.C. (“MHM”), Blue Water Biotech, Inc.’s (the “Company”) independent registered public accounting firm, informed the Company that it resigned, effective June 29, 2023.

View on SEC.gov

16 auditor changes filed in the last 30 days. Browse all auditor changes →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-055199

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.